Get the Stockscreener App
348.60
0.08%
-0.82
Overview
News
Price History
Option Chain
Financials
Why WST Down?
Discussions
Forecast
Stock Split
Dividend History
West Pharmaceutical Services Inc stock is traded at $348.60, with a volume of 104.71K.
It is down -0.08% in the last 24 hours and down -2.54% over the past month.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
See More
Previous Close:
$349.42
Open:
$348
24h Volume:
104.71K
Relative Volume:
0.14
Market Cap:
$24.53B
Revenue:
$3.22B
Net Income/Loss:
$542.70M
P/E Ratio:
46.60
EPS:
7.4805
Net Cash Flow:
$458.00M
1W Performance:
-0.85%
1M Performance:
-2.54%
6M Performance:
+43.57%
1Y Performance:
+41.82%
1-Day Range:
$348.00
$350.74
1-Week Range:
$343.48
$354.57
52-Week Range:
$223.83
$386.00
West Pharmaceutical Services Inc Stock (WST) Company Profile
Name
West Pharmaceutical Services Inc
Sector
Industry
Phone
(610) 594-2900
Address
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
348.58 | 24.59B | 3.22B | 542.70M | 458.00M | 7.4805 |
ISRG
Intuitive Surgical Inc
|
391.20 | 139.37B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
182.07 | 49.96B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
72.61 | 35.89B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
220.21 | 32.38B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
34.69 | 31.36B | 29.14B | 1.07B | 1.05B | 1.1956 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-25 | Initiated | Rothschild & Co Redburn | Buy |
| Jun-24-25 | Initiated | Barclays | Equal Weight |
| Mar-18-25 | Initiated | Evercore ISI | Outperform |
| Feb-14-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-08-25 | Initiated | Citigroup | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
| Dec-12-24 | Upgrade | UBS | Neutral → Buy |
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-11-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Nov-30-22 | Initiated | UBS | Neutral |
| Oct-28-22 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-14-20 | Initiated | Stephens | Equal-Weight |
| Jul-21-20 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-24-20 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Dec-12-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| May-01-19 | Downgrade | Jefferies | Buy → Hold |
| Apr-23-19 | Initiated | William Blair | Outperform |
| Apr-25-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-24-18 | Initiated | Goldman | Neutral |
| Oct-17-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-03-17 | Initiated | Stephens | Equal-Weight |
| Sep-15-17 | Upgrade | Jefferies | Hold → Buy |
| Oct-28-16 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Sep-21-16 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Mar-22-16 | Initiated | Wells Fargo | Outperform |
| May-14-10 | Reiterated | UBS | Neutral |
| Feb-23-10 | Initiated | Jefferies & Co | Buy |
| Dec-19-08 | Initiated | UBS | Neutral |
View All
West Pharmaceutical Services Inc Stock (WST) Latest News
Is West Pharmaceutical Services (WST) Undervalued After Its Run to $349.42? - Sahm
WST Stock Surges 38.1% Since March-End: What's Fueling the Rally? - TradingView
West Pharmaceutical (WST) Upgraded to Buy: Here's Why - Yahoo Finance
Zacks Research Has Optimistic Outlook of WST Q3 Earnings - MarketBeat
West Pharmaceutical Services (NYSE:WST) Rating Lowered to Hold at Zacks Research - MarketBeat
Israel Business NewsGlobes - Globes - Israel Business News
West Pharmaceutical Services Inc. stock underperforms Thursday when compared to competitors - MarketWatch
WST Gains 15.3% in Three Months as HVP Growth Strengthens Outlook - TradingView
West Pharmaceutical Services, Inc. $WST Stock Position Reduced by Handelsbanken Fonder AB - MarketBeat
Wasatch Advisors LP Acquires Shares of 24,670 West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services, I (WST) Stock Forecasts - Yahoo Finance
West Pharmaceutical CFO Robert W. McMahon Reports RSU Vesting and Share Withholding Transactions - Kalkine Media
West Pharmaceutical (WST) CFO converts RSUs, withholds shares for taxes - Stock Titan
Here's Why You Should Add BrightSpring Stock to Your Portfolio Now - TradingView
West (WST) Stock Looks Overvalued After A 47% One Year Run - finance.yahoo.com
Wrapped West Pharmaceutical Services Tokenized Stock (xStock) News - CoinMarketCap
CAH Q4 Earnings Beat on Pharma Strength, Revenues Miss, Stock Up - TradingView
TWIN CAPITAL MANAGEMENT INC's West Pharmaceutical Services Inc(WST) Holding History - GuruFocus
West Pharmaceutical Services, Inc. (WST) options chain - Yahoo Finance UK
Select Medical Technology and Devices Portfolio's West Pharmaceutical Services Inc(WST) Holding History - GuruFocus
POSTROCK PARTNERS LLC's West Pharmaceutical Services Inc(WST) Holding History - GuruFocus
West Pharmaceutical Services Inc (WST) Stock Price, Trades & News - GuruFocus
West Pharmaceutical Services, Inc. (WST) Stock Analysis: A 14% Upside Potential with Strong Buy Ratings - directorstalkinterviews.com
Assenagon Asset Management S.A. Has $23.25 Million Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
ETFs Investing in West Pharmaceutical Services, Inc. Stocks - TradingView
On-body Injector Market Size, Share, Trends, Report, 2026-2035 - Global Market Insights Inc.
West Pharmaceutical Services, Inc. $WST Position Reduced by Seilern Investment Management Ltd - MarketBeat
Bank of America Corp DE Sells 150,033 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Pharmaceutical-Grade Aluminum Closures Market Outlook to 2035 - IndexBox
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharmaceutical Services Inc (WST) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
FMR LLC reports 5.0% ownership of West Pharmaceutical (WST) common stock - Stock Titan
Broad-Based Growth Lifted West Pharmaceuticals (WST) in Q2 - Yahoo Finance
West Pharmaceutical Services declares Q3 2026 distribution of R$ 0.02 per unit - Bitget
West Pharmaceutical Services, Inc. (NYSE:WST) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Shareholders of West Pharmaceutical Services, Inc. (WST): Protect - The National Law Review
Redwood Investment Management LLC Makes New Investment in West Pharmaceutical Services, Inc. $WST - MarketBeat
Stronger Q2 Results, Guidance Hike, Buybacks Might Change The Case For Investing In West (WST) - Sahm
Securities Fraud Class Action Filed Against West Pharmaceutical S - The National Law Review
Citi Initiates West Pharmaceutical Services(WST.US) With Buy Rating, Announces Target Price $412 - Moomoo
West Pharmaceutical Services (WST) Stock Analysis: A Potential 18.7% Upside Awaits Investors - directorstalkinterviews.com
West Pharmaceutical Services (WST) Raised Guidance, Is The Upside Already Priced In? - Yahoo Finance
Is Stronger Q2 Results, Raised Outlook and Buybacks Altering The Investment Case For West Pharmaceutical Services (WST)? - Yahoo Finance
Royal Bank of Canada Sells 67,308 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Quantinno Capital Management LP Increases Stock Holdings in West Pharmaceutical Services, Inc. $WST - MarketBeat
The 5 Most Interesting Analyst Questions From West Pharmaceutical Services’s Q2 Earnings Call - The Globe and Mail
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Healthcare of Ontario Pension Plan Trust Fund Has $12.66 Million Stake in West Pharmaceutical Services, Inc. $WST - MarketBeat
WST Maintains Rating by Evercore ISI Group -- Price Target Raised to $425 - GuruFocus
WEST PHARMACEUTICAL SERVICES INC : EVERCORE ISI RAISES TARGET PRICE TO $425 FROM $410 - Bitget
BNP Paribas Adjusts PT on West Pharmaceutical Services to $459 From $447, Maintains Outperform Rating - marketscreener.com
West Pharmaceutical Services Inc Stock (WST) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):